chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Dyspnoea, Gait disturbance, Wheezing
Clinical narrative: Got vaccine at 7:30 PM.  On 4/6/2021 woke up at 2:20 AM with RIGORS.  No fever.  Difficulty walking.  Wheezing and trouble breathing.  In ER initial pulsox was 88% but reduced to 42% and difficult to obtain BP.  Given oxygen, epinephrine, magnesium, steroids and albuterol.  Discharged but continues with coughing and wheezing.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Headache, Injection site pain
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia, Tinnitus
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Chills, Computerised tomogram, Computerised tomogram head, Decreased appetite
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Fatigue, Gastrointestinal pain
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glomerular filtration rate, Headache, Hypotension, Insomnia, Laboratory test
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Parosmia, Pyrexia, Tinnitus
Clinical narrative: Day 5 after vaccine I  got fever, chills, and loud ringing(tinnitus) in both ears.  Followed by headache, fatigue, dizziness, strange ammonia like smell in my nose, shortness of breath, yellow diarrhea, intestinal pain, insomnia, and lack of appetite.  Have been very sick for the last 4 weeks and continuing.  Have had lowered Blood pressure, elevated fasting glucose, and kidney GFR effected also.  The constant ear ringing is just horrible!!!
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Thrombosis
Clinical narrative: Saddle pulmonary embolism, DVT of left femoral, tibial, and popliteal veins, with associated thrombocytopenia.  PE caused right heart strain and troponin elevation.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Coagulation factor V level normal, Deep vein thrombosis, Echocardiogram abnormal, Factor II mutation
Clinical narrative: Saddle pulmonary embolism, DVT of left femoral, tibial, and popliteal veins, with associated thrombocytopenia.  PE caused right heart strain and troponin elevation.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Platelet count decreased, Pulmonary embolism, Right ventricular dysfunction, Thrombocytopenia
Clinical narrative: Saddle pulmonary embolism, DVT of left femoral, tibial, and popliteal veins, with associated thrombocytopenia.  PE caused right heart strain and troponin elevation.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, Tumour marker test, Ultrasound Doppler abnormal
Clinical narrative: Saddle pulmonary embolism, DVT of left femoral, tibial, and popliteal veins, with associated thrombocytopenia.  PE caused right heart strain and troponin elevation.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Fatigue, Headache, Hypertension, Panic attack
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Arthralgia, Blood pressure increased, Blood pressure measurement, Dizziness
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza like illness, Muscle spasms, Nausea, Neuralgia, Pruritus
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sinus congestion, Spinal pain, Swelling face, Tremor, Vision blurred
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Blood pressure fluctuation, Cold sweat, Dizziness, Heart rate increased
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza, Insomnia, Myalgia
Clinical narrative: SINUS CLOGGED/ SINUS HEADACHE; SHOOTING NERVE PAIN IN BACK; FACE SWOLLEN; SHAKES; ITCHY; SHARP NERVE PAIN IN SPINE; INCREASED BLOOD PRESSURE; FEELING LIKE FLU; ARTHRITIC PAIN; LEG CRAMPS; NAUSEA; DIZZINESS; ANXIETY; BLURRING OF EYES; This spontaneous report received from a patient concerned a 49-year-old  female. The patient's weight was 185 pounds, and height was not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in APR-2021, Laboratory data included: Blood pressure (NR: not provided) 160/90 mmHg.  On 08-APR-2021, within 5 minutes after vaccination the patient experienced dizziness, chills with shakes, nausea, anxiety and 20 minutes later she was evaluated by an emergency medical services onsite. On 08-Apr-2021, Blood pressure (BP) reading was 240/130 mmHg. She was kept under evaluation at the vaccination site until BP was 160/90. She experienced pain (body aches, shooting nerve pain in back with itching, arthritic pain from neck to spine and in hands) which began around midnight on 09-Apr-2021 and in morning she experienced full blown flu (ringing of ears, face swollen, sinus clogged, headache, body ache, chill). On 09-Apr-2021, Blood pressure (BP) reading was 153/87 mmHg The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizziness, blurring of eyes, and nausea on 08-APR-2021, had not recovered from increased blood pressure, itchy, arthritic pain, sharp nerve pain in spine, leg cramps, feeling like flu, and anxiety, and the outcome of sinus clogged/ sinus headache, shooting nerve pain in back, face swollen and shakes was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210417592-Covid-19 vaccine ad26.cov2.s-Increased blood pressure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Dyspnoea, Hyperhidrosis, Nausea
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin discolouration, Skin warm, Vital signs measurement, Vomiting
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Axillary pain, Blood pressure decreased, Dizziness, Electrocardiogram normal, Laboratory test abnormal
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual impairment, Vomiting
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dizziness postural, Hyperhidrosis, Immediate post-injection reaction, Mobility decreased
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Visual impairment, Vomiting
Clinical narrative: Patient has a history of allergic reactions to iodine and presented to the ED for evaluation of lightheadedness, dizziness, nausea, vomiting. Patient states that this afternoon she received the Johnson and Johnson COVID-19 vaccine at the Arena and within a minute she began to have a reaction. Patient describes the event as she got up to walk to the observation room and was unable to make it to her chair before she began to sweat profusely, become exceptionally nauseous, and dizzy. She describes her dizziness as so severe that she was unable to stand or move at all. Patient also endorses seeing "black spots" in her vision and saying that she was going to pass out. Patient reports several episodes of vomiting that did stop until the staff present placed an IV and gave her Zofran. Patient denies any throat swelling, wheezing or trouble breathing. On examination patient reports that all of her symptoms resolved within 40 minutes of onset without any other treatment than Zofran.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram head, Computerised tomogram normal, Confusional state
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear pain, Facial paralysis, Headache, Magnetic resonance imaging head normal, Vertigo
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral normal, Arteriogram carotid normal, Bell's palsy, Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, C-reactive protein normal, Computerised tomogram head normal, Ear pain, Electrocardiogram normal
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Fatigue, Feeling abnormal, Full blood count normal, Glycosylated haemoglobin
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lipids normal, Magnetic resonance imaging head normal, Metabolic function test normal, Pain in jaw, Perfusion brain scan normal
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Sensory loss, Thromboelastogram, Tinnitus, Troponin normal
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis normal, Vitamin D
Clinical narrative: on 4/3 patient developed left sided facial droop and loss of sensation. Admitted to hospital and diagnosed with Bell's Palsy. Treated with a prednisone taper. Still having left sided facial droop, left sided tinnitus, left sided ear pain and jaw pain as well as fatigue and brain fog on 4/19 at follow up visit. Treated with a course of valacyclovir for 1 week at this time.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dizziness, Erythema, Feeling hot, Headache
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Rash, Vomiting
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Nausea, Syncope
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse reaction, Ageusia, Arthralgia, Decreased appetite, Dysgeusia
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema, Feeling abnormal, Glossodynia, Hot flush, Nausea
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swollen tongue, Tongue exfoliation, Vomiting
Clinical narrative: HOT FLASH; NAUSEA; JOINT PAIN/JOINT BURNING; FOGGINESS; VOMITING; FACIAL REDNESS; METALLIC TASTE; APPETITE LOST; SWOLLEN TONGUE; PAIN TONGUE; PEELING TONGUE; ADVERSE REACTION; LOSS OF TASTE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 04DDZ1D expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced hot flash. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced joint pain/joint burning. On APR-2021, the subject experienced fogginess. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced facial redness. On APR-2021, the subject experienced metallic taste. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced swollen tongue. On APR-2021, the subject experienced pain tongue. On APR-2021, the subject experienced peeling tongue. On APR-2021, the subject experienced adverse reaction. On APR-2021, the subject experienced loss of taste. The dose of covid-19 vaccine ad26.cov2.s was increased. The outcome of the hot flash, nausea, joint pain/joint burning, fogginess, vomiting, facial redness, metallic taste, appetite lost, swollen tongue, pain tongue, peeling tongue, adverse reaction and loss of taste was not reported. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Pain
Clinical narrative: Initially had two days of normal soreness which resolves then on 7 April 2021 she noted  the soreness returned to the arm causing her decreased ROM secondary to the pain Caller states she called her doctor who advised to move the arm more to out work  out the soreness which she really hasn't been doing  4/13-f/u call made; minimal changes in symptoms; continues to increase ROM and using heating pad PRN
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Initially had two days of normal soreness which resolves then on 7 April 2021 she noted  the soreness returned to the arm causing her decreased ROM secondary to the pain Caller states she called her doctor who advised to move the arm more to out work  out the soreness which she really hasn't been doing  4/13-f/u call made; minimal changes in symptoms; continues to increase ROM and using heating pad PRN
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acne, Feeling hot, Genital rash, Pruritus, Rash
Clinical narrative: pt says she developed a full body rash.  About a week and a half later she is now experiencing  headaches, depression, a metallic taste in her mouth, head pressure, feeling of being high or that her brain is swelling, nausea, and numbness in the last three fingers in both hands.  She says her heart rate is really fast.  On 4/19/2021  BP was 191/102.  The did EKG that was normal and lab work.  Pt has not received lab results.  Pt says she will go to the ER today since she is still having all of these symptoms and she could not get our of bed to go to work.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Depression, Dysgeusia, Electrocardiogram normal, Head discomfort
Clinical narrative: pt says she developed a full body rash.  About a week and a half later she is now experiencing  headaches, depression, a metallic taste in her mouth, head pressure, feeling of being high or that her brain is swelling, nausea, and numbness in the last three fingers in both hands.  She says her heart rate is really fast.  On 4/19/2021  BP was 191/102.  The did EKG that was normal and lab work.  Pt has not received lab results.  Pt says she will go to the ER today since she is still having all of these symptoms and she could not get our of bed to go to work.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hypoaesthesia, Impaired work ability, Nausea
Clinical narrative: pt says she developed a full body rash.  About a week and a half later she is now experiencing  headaches, depression, a metallic taste in her mouth, head pressure, feeling of being high or that her brain is swelling, nausea, and numbness in the last three fingers in both hands.  She says her heart rate is really fast.  On 4/19/2021  BP was 191/102.  The did EKG that was normal and lab work.  Pt has not received lab results.  Pt says she will go to the ER today since she is still having all of these symptoms and she could not get our of bed to go to work.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: pt says she developed a full body rash.  About a week and a half later she is now experiencing  headaches, depression, a metallic taste in her mouth, head pressure, feeling of being high or that her brain is swelling, nausea, and numbness in the last three fingers in both hands.  She says her heart rate is really fast.  On 4/19/2021  BP was 191/102.  The did EKG that was normal and lab work.  Pt has not received lab results.  Pt says she will go to the ER today since she is still having all of these symptoms and she could not get our of bed to go to work.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient received vaccine at age 17